ImmuCell Corporation (ICCC) Q3 Revenue Rises 46% to $8.0M

ImmuCell reported unaudited Q3 2026 revenue of $8.0M, up 46.0% year over year, and net income of $953K, up $1.1M. Gross margin was 44.2%, up 130 basis points year over year.Material DetailsContext by AI AnalystThis is a quarterly results update showing improved revenue, profitability and margins, w…